Retail & Wholesale » Retail | China Pioneer Pharma Holdings Ltd.

China Pioneer Pharma Holdings Ltd. | Cash Flow

Fiscal year is January-December. All values HKD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
343,800.50
383,458.80
255,077.60
329,903.00
356,669.40
126,871.60
Depreciation, Depletion & Amortization
2,846.40
9,566.10
20,822.40
15,399.80
9,592.50
9,577.50
Other Funds
148,648.10
-
-
-
-
43,886.40
Funds from Operations
314,054.30
368,177.80
342,346.40
327,560.30
305,540.40
180,335.50
Changes in Working Capital
240,478.40
350,418.70
69,409.20
80,285.50
32,036.20
23,955.60
Net Operating Cash Flow
73,575.80
17,759.10
411,755.60
407,845.80
273,504.10
156,379.90
Capital Expenditures
20,227.90
57,629.30
9,558.20
9,310.00
12,206.60
Sale of Fixed Assets & Businesses
1,901.40
2,271.60
32,089.00
590.10
553.50
Purchase/Sale of Investments
181,517.10
137,840.40
43,882.30
70,614.50
-
Net Investing Cash Flow
156,130.10
209,533.80
17,455.00
61,863.10
41,619.50
Cash Dividends Paid - Total
289,730.90
322,172.20
231,624.20
166,499.60
248,252.70
Issuance/Reduction of Debt, Net
16,812.40
232,821.70
411,686.50
237,756.80
54,484.50
Net Financing Cash Flow
889,470.90
89,350.60
827,686.50
405,333.70
349,737.00
Net Change in Cash
807,762.10
285,871.20
430,641.40
55,290.70
36,597.80
Free Cash Flow
53,348.00
31,923.90
404,170.90
401,778.20
262,289.20
Net Assets from Acquisitions
-
91,847.50
-
-
2,338.50
Other Sources
53,807.20
75,511.80
-
26,963.60
55,611.10
Change in Capital Stock
1,311,037.50
-
184,375.80
1,077.30
46,999.80
Exchange Rate Effect
845.40
4,745.90
2,744.50
4,060.30
1,984.50
Other Uses
10,093.70
-
19,690.10
8,312.10
-

About China Pioneer Pharma Holdings

View Profile
Address
No.15, Lane 88 Wuwei Road
Shanghai Shanghai 200331
China
Employees -
Website http://www.pioneer-pharma.com
Updated 07/08/2019
China Pioneer Pharma Holdings Ltd. is an investment company, which engages in the manufacture, promotion, and sale of pharmaceutical products. It operates through the Ophthalmic Pharmaceutical Products and Group's Pharmaceutical Products and Medical Devices Except for Ophthalmic Pharmaceutical Products segments. The Ophthalmic Pharmaceutical Products segment involves in the sales of the Group's ophthalmic pharmaceutical products to the customers under the co-promotion and channel management arrangement.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.